Health Catalyst Q3 EPS $(0.27) Beats $(0.37) Estimate, Sales $39.423M Beat $37.71M Estimate

Health Catalyst (NASDAQ:HCAT) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.37) by 27.03 percent. The company reported quarterly sales of $39.423 million which beat the

Benzinga · 11/12/2019 21:47

Health Catalyst (NASDAQ:HCAT) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.37) by 27.03 percent. The company reported quarterly sales of $39.423 million which beat the analyst consensus estimate of $37.71 million by 4.54 percent. This is a 19.94 percent increase over sales of $32.868 million the same period last year.